Why is CRO-sponsor collaboration so difficult in clinical trials?

Most collaboration failures trace back to the selection process rather than the execution. When sponsors find partners through conferences and referral networks rather than verified clinical fit, the relationship starts misaligned. 45% of sponsors rate their CRO experience as moderately or completely unsatisfactory — not because CROs are performing poorly, but because the match was wrong from the start.

What are the most common causes of CRO-sponsor relationship breakdown?

The top issues are misaligned expectations on deliverables and timelines, communication gaps between sponsor teams and CRO project managers, and a mismatch between the sponsor's program requirements and the CRO's actual therapeutic area depth. Many of these stem from the selection process relying on brand recognition rather than specific clinical track record.

How can sponsors improve the CRO selection process?

The most effective change is shifting from reputation-based search to evidence-based search — looking at a CRO's verified proposal and project history in the relevant therapeutic area, phase, and geography rather than relying on conference introductions or incumbent relationships. The right match at the start dramatically reduces friction throughout the engagement.

What does successful CRO-sponsor collaboration look like in practice?

Strong partnerships are characterized by clear scope alignment before contract signing, a single point of contact on each side with decision-making authority, proactive issue escalation rather than reactive problem management, and mutual investment in understanding each other's operational constraints. The best relationships are built on specific expertise match, not just availability and price.

How does the clinical trial partner discovery process affect collaboration outcomes?

The discovery process sets the ceiling on collaboration quality. A sponsor who finds a CRO through a warm referral and selects them based on brand recognition has less validated fit information than a sponsor who searched by therapeutic area, phase, regulatory environment, and verified submission history. Better discovery leads to better-matched partnerships — and better-matched partnerships collaborate more effectively.

Insights

Dave Anderson 5/31/26 Dave Anderson 5/31/26

The Hidden Cost of Starting Every Proposal From Scratch

Over the past few months, we interviewed several clinical supply leaders to explore the challenges and opportunities in effectively planning and forecasting for increasingly complex trials.

Bridging the Gap: 5 Ways to Enhance CRO-Sponsor Collaboration

Our VP of Client Services, John O’Brien, PharmD, shares advice from his decade of experience at Pfizer, Gilead, and BeiGene for keys to a successful partnership.

Insights

The Hidden Cost of Starting Every Proposal From Scratch

Bridging the Gap: 5 Ways to Enhance CRO-Sponsor Collaboration

Subscribe